Milestone Consulting, New York

HomeNew YorkMilestone Consulting

John Bair

New Living Safer: Taking a Closer Look at Medicating in America

There is no doubt that modern medical advances have done amazing things for patients who need treatment, but many argue the pharmaceutical industry is still fraught with dangerous problems. For one, the field is run by multibillion-dollar drug manufacturers who […]

John Bair

Managing the Risk and Pain of Opioid Addiction

At Milestone Consulting, we assist many injured clients who remain heavily medicated for their pain long after their lawsuits have been resolved. For those who have been prescribed opioid drugs, the medication they depend on for relief can tragically come […]

John Bair

What the Supreme Court’s BMS Decision Means for Plaintiffs

For hundreds of plaintiffs and attorneys in mass tort litigations involving Plavix, Talcum Powder, Essure and other allegedly harmful products, a recent Supreme Court ruling could have huge implications for the future of their cases. In a case titled Bristol-Myers […]

John Bair

Did Anti-Anxiety Medication Contribute to Chris Cornell’s Suicide?

The music world was rocked last week by news of Soundgarden singer and guitarist Chris Cornell’s death — and again when it was determined to be a suicide. But Cornell’s wife is speculating that too much anti-anxiety medicine might have […]

John Bair

The SSRI Wars: Protecting Others While Putting Life Back Together

For more than a decade, there has been talk about the lesser-known side effects of a class of antidepressants and antipsychotic medication called selective serotonin reuptake inhibitors (SSRIs). Families have claimed these drugs — which include Paxil, Zoloft, Lexapro, and […]

John Bair

Fighting Bills that Endanger Our Access to Justice

The civil justice system is in jeopardy. A series of tort reform bills coming to the floor in early March could be devastating to Americans’ access to justice. Last week, I talked about H.R. 985, which seeks to eliminate the […]

John Bair

Risperdal Gynecomastia Plaintiffs: Looking Ahead to Possible Settlement

The antipsychotic drug Risperdal has been linked to gynecomastia – the growth of breast tissue in boys and men. Now, thousands of Risperdal cases have been filed in Los Angeles and Philadelphia to hold pharmaceutical manufacturer Johnson & Johnson accountable […]

John Bair

Four Female Attorneys Appointed to Invokana PSC

Last week, Judge Brian R. Martinotti of the United States District Court for the District of New Jersey appointed four outstanding women to the 14-member plaintiffs’ steering committee (PSC) in MDL 2750 for Invokana (Canagliflozin) Products Liability Litigation. Judge Martinotti’s […]

John Bair

Sign the Petition to Close Generic Drug Loophole Today

In modern America, we are blessed to have easy access to a plethora of prescription drug options when we fall ill. These drugs and the positive impact they have on our health and well-being are nothing short of a minor […]